ABOUT

India’s Novel Innovation for Sepsis Management

To revolutionize Sepsis management, Cadila Pharmaceuticals introduces Sepsivac, an immunotherapy treatment. It’s India’s Novel innovation in Sepsis management and the drug has received approval from Drug Controller General of India (DCGI) for immunotherapy treatment in Sepsis or septic shock.
Know More

EVIDENCE

Sepsivac in Gram –ve Sepsis


Know More

Mycobacterium w


Know More

CARE STORIES

Recovery takes time. You will begin by slowly building up immunity.


I survived Sepsis - Anand In Quote Form

WHAT'S NEW

Cadila’s Sepsivac gets Philippines’ nod
Know More
Sepsivac has 70% efficacy against Covid-19: Study
Know More
The Hindu business line: Is there a way to tame the Covid virus?-NK Ganguly/Suparno Chakrabarti
Know More
Sepsivac effective in boosting innate immunity, building resistance to COVID-19:Study
Know More
Sepsivac effective in boosting innate immunity, building resistance to COVID-19: Study
Know More

WEBINAR LIBRARY

WEBINAR LIBRARY

PHARMACOVIGILANCE

If you want to report adverse drug reaction, kindly write to us at pharmacovigilance@cadilapharma.co.in

Report Form

REACH US

For any queries reach us at sepsivac@cadilapharma.co.in